https://www.eurekalert.org/news-releases/1007163
0
0
11/7/23 at 2:01am
Organization
EurekAlert
55 words
0
Comments
<p>Researchers combined the features of clinical drugs to treat hepatitis C and viruses similar to COVID-19. This allowed them to synthesize BBH-1, a promising inhibitor that targets the breakdown of the SARS-CoV-2 virus. The researchers characterized samples…
You are the first to view
Create an account
or login to join the discussion